☆ 4.5 Article

Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial

Muthiah Vaduganathan et al.

Summary: Dronedarone is associated with reduced cardiovascular events in patients with atrial fibrillation/flutter (AF/AFL) and concomitant heart failure (HF), including those with preserved ejection fraction (HFpEF) and mildly reduced ejection fraction (HFmrEF). Further clinical trials are needed to confirm the clinical benefits of dronedarone in this population.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Paul A. Heidenreich et al.

Summary: This article provides an overview of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, including its aim, methods, and structure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial

Maja Cikes et al.

Summary: The study found that a history of AFF and presence of AFF at enrollment were associated with a higher risk of adverse outcomes in HFpEF patients. Additionally, first-detected AFF was not influenced by sacubitril/valsartan treatment, but was linked to increased risk of subsequent outcomes.

JACC-HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction

Jawad H. Butt et al.

Summary: This study examined the effects of dapagliflozin in patients with atrial fibrillation (AF) and found that its benefits were consistent across different types of AF.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction

Patricia Palau et al.

Summary: This study aimed to evaluate the effect of beta-blocker withdrawal on peak oxygen consumption in patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence. The results showed that beta-blocker withdrawal significantly improved maximal functional capacity in these patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial

Douglas L. Packer et al.

Summary: The CABANA trial showed that catheter ablation in patients with heart failure and atrial fibrillation can significantly improve survival, reduce AF recurrence, and enhance quality of life compared to drug therapy.

CIRCULATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Ravi B. Patel et al.

Summary: In HFpEF, disproportionate LA myopathy may indicate better LV diastolic function but is associated with lower stroke volume reserve after passive leg raise independent of AF. Additionally, disproportionate LA myopathy is linked to higher pulmonary artery systolic pressure, higher pulmonary vascular resistance, and lower coronary flow reserve.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type

Jae-Sun Uhm et al.

Summary: The study aimed to investigate the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to different types of heart failure. The highest risk was observed in the HFpEF group, while the risk was comparable between the HFmrEF and HFrEF groups.

ESC HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

Andreas Rillig et al.

Summary: The study demonstrates that early rhythm control therapy is beneficial in reducing cardiovascular events in patients with heart failure and atrial fibrillation. Additionally, the therapy helps to improve left ventricular ejection fraction in heart failure patients.

CIRCULATION (2021)

Add to Collection

Article Medicine, General & Internal

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker et al.

Summary: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Interdependence of Atrial Fibrillation and Heart Failure With a Preserved Ejection Fraction Reflects a Common Underlying Atrial and Ventricular Myopathy

Milton Packer et al.

CIRCULATION (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction

Ravi B. Patel et al.

JAMA CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction

Mi Kyoung Son et al.

HEART (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

Yogesh N.V. Reddy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable First Results From Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB)

Jonathan P. Piccini et al.

CIRCULATION (2019)

Add to Collection

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

S. D. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

Ravi B. Patel et al.

JACC-HEART FAILURE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure

Jacob P. Kelly et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort

Parag Goyal et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction The TOPCAT Trial

Maja Cikes et al.

JACC-HEART FAILURE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry

Barak Zafrir et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume

Carolyn S. P. Lam et al.

JACC-HEART FAILURE (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

Ulrik Sartipy et al.

JACC-HEART FAILURE (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation Begets Heart Failure and Vice Versa Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction

Rajalakshmi Santhanakrishnan et al.

CIRCULATION (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Craig T. January et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study

Rosita Zakeri et al.

CIRCULATION (2013)

Add to Collection

Article Medicine, General & Internal

Increased mortality after dronedarone therapy for severe heart failure

Lars Kober et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.